↓ Skip to main content

A Randomized Controlled Trial of Granulocyte Colony-Stimulating Factor for the Treatment of Severe Sepsis Due to Melioidosis in Thailand

Overview of attention for article published in Clinical Infectious Diseases, June 2007
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)
  • Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

policy
1 policy source
twitter
1 X user
patent
1 patent
wikipedia
1 Wikipedia page
f1000
1 research highlight platform

Citations

dimensions_citation
85 Dimensions

Readers on

mendeley
53 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A Randomized Controlled Trial of Granulocyte Colony-Stimulating Factor for the Treatment of Severe Sepsis Due to Melioidosis in Thailand
Published in
Clinical Infectious Diseases, June 2007
DOI 10.1086/519261
Pubmed ID
Authors

Allen C. Cheng, Direk Limmathurotsakul, Wirongrong Chierakul, Nongluk Getchalarat, Vanaporn Wuthiekanun, Dianne P. Stephens, Nicholas P. J. Day, Nicholas J. White, Wipada Chaowagul, Bart J. Currie, Sharon J. Peacock

Abstract

Melioidosis is a tropical infectious disease associated with significant mortality. Most deaths occur early and are caused by fulminant sepsis.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 53 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Thailand 1 2%
Unknown 52 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 8 15%
Student > Ph. D. Student 7 13%
Researcher 6 11%
Student > Postgraduate 5 9%
Professor 3 6%
Other 10 19%
Unknown 14 26%
Readers by discipline Count As %
Medicine and Dentistry 21 40%
Agricultural and Biological Sciences 4 8%
Pharmacology, Toxicology and Pharmaceutical Science 3 6%
Immunology and Microbiology 3 6%
Biochemistry, Genetics and Molecular Biology 2 4%
Other 6 11%
Unknown 14 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 April 2020.
All research outputs
#3,274,688
of 25,374,647 outputs
Outputs from Clinical Infectious Diseases
#5,165
of 16,853 outputs
Outputs of similar age
#8,232
of 81,226 outputs
Outputs of similar age from Clinical Infectious Diseases
#30
of 107 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 16,853 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 31.7. This one has gotten more attention than average, scoring higher than 69% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 81,226 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 107 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.